Crinetics Pharmaceuticals, Inc.

company in San Diego, United States

CRNX Nasdaq SEC CIK 1658247
Follow Crinetics Pharmaceuticals Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $25.1M +2336.3% vs same quarter last year
Net income −$120.9M −4.5% vs same quarter last year
EPS, diluted −$1.14 +7.3% vs same quarter last year
Operating cash flow −$94.2M −9.7% vs same quarter last year
Revenue by quarter
$0
$0
$361K
$1M
$143K
$6.2M
$10.7M
$25.1M
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income11 fiscal years
  • Revenue
  • Net income
−$600M−$400M−$200M$0$200MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$7.7M−$465.3M
FY24$1M−$298.4M
FY23$4M−$214.5M
FY22$0−$163.9M
FY21$0−$107.6M
FY20$71K−$73.8M
FY19$1.2M−$50.4M
FY18$2.4M−$27.1M
FY17$2M−$9.2M
FY16$589K−$6M
FY15--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−150000%−100000%−50000%0%50000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2586%−6714.8%−6046%
FY24100%−32613.5%−28719.9%
FY23100%−5547.2%−5345.1%
FY22---
FY21---
FY20-−105567.6%−103960.6%
FY19-−4512.3%−4226.5%
FY18-−1182.5%−1116.8%
FY17-−446.3%−447.8%
FY16-−1026.1%−1021.9%
FY15---
Free cash flowOperating cash flow minus capital expenditure
−$400M−$300M−$200M−$100M$0FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$383.7M
FY24−$234M
FY23−$173.3M
FY22−$116.9M
FY21−$89M
FY20−$62.2M
FY19−$46.9M
FY18−$20.5M
FY17−$9.8M
FY16−$5.7M
FY15-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Crinetics Pharmaceuticals
  • Healthcare median
−150000%−100000%−50000%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearCrinetics PharmaceuticalsHealthcare median
FY25−6046%−40.6%
FY24−28719.9%−60.7%
FY23−5345.1%−97.1%
FY22-−128.5%
FY21-−129.2%
FY20−103960.6%−136.5%
FY19−4226.5%−133.7%
FY18−1116.8%−173.4%
FY17−447.8%−176.7%
FY16−1021.9%−164.8%
FY15-−183.4%

News

No stories filed under Crinetics Pharmaceuticals yet - coverage appears here as the news feed clusters it.